Search

everythinglearnresearchcommunity

for

Search:↓

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Higher antigliadin antibody levels are linked to alopecia areata severity.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Finasteride helps female-pattern hair loss.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Reflectance confocal microscopy can help tell apart scarring from non-scarring hair loss.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Low vitamin D levels are linked to different types of hair loss.

People with alopecia areata often have lower vitamin D levels than healthy people.